{"disease":{"id":"hereditary-hemorrhagic-telangiectasia","name":"hereditary hemorrhagic telangiectasia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01158807","title":"Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2272,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT03695874","title":"Development of a Quality of Life Measurement Scale in Hereditary Haemorrhagic Telangiectasia (HHT) Disease.","phase":"","overall_status":"COMPLETED","enrollment_count":643,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07101575","title":"Cardiac Evaluation in Hereditary Hemorrhagic Telangiectasia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":380,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06573723","title":"Institutional Registry of Rare Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":380,"lead_sponsor_name":"Hospital Italiano de Buenos Aires","has_results":false},{"nct_id":"NCT04150822","title":"CHORUS - Comprehensive HHT Outcomes Registry of the United States (Formerly OUR HHT Registry)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":296,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT06261333","title":"Quality of Life in Patients With Hemorrhagic Telangiectasia","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":250,"lead_sponsor_name":"University Hospital, Essen","has_results":false},{"nct_id":"NCT03691142","title":"Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT)","phase":"","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07191639","title":"Description of the Impact of Symptoms on Quality of Life in HHT Disease: DISQUO","phase":"","overall_status":"COMPLETED","enrollment_count":185,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06659640","title":"A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Alnylam Pharmaceuticals","has_results":false},{"nct_id":"NCT04469517","title":"Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Hospital, Essen","has_results":false},{"nct_id":"NCT05550376","title":"Genotype-phenotype Association in Hereditary Hemorrhagic Telangiectasia","phase":"","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","has_results":false},{"nct_id":"NCT07018401","title":"Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia Longitudinal Assessment Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":62,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03572556","title":"Prospective Descriptive Study of the Angiogenic T Cell Population in Subjects With Hereditary Hemorrhagic Telangiectasia (HHT)","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT05752253","title":"Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era.","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05954481","title":"Stress-Echography in Hereditary Haemorrhagic Telangiectasia Patient With Hepatic Involvement","phase":"NA","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT02389959","title":"Intranasal Bevacizumab for HHT-Related Epistaxis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Stanford University","has_results":true},{"nct_id":"NCT04404881","title":"Bevacizumab In Hereditary Hemorrhagic Telangiectasia","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":33,"lead_sponsor_name":"Hanny Al-Samkari, MD","has_results":false},{"nct_id":"NCT03850730","title":"Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Cure HHT","has_results":false},{"nct_id":"NCT04139018","title":"Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT04113187","title":"Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT03397004","title":"Doxycycline for Hereditary Hemorrhagic Telangiectasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT05269849","title":"Sirolimus for Nosebleeds in HHT","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT04874558","title":"Ultra-low-dose Chest CT for HHT","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT01402531","title":"Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"University of California, San Diego","has_results":true},{"nct_id":"NCT04646356","title":"Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT02287558","title":"Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"The Cleveland Clinic","has_results":false}],"total":26},"guidelines":[],"source":"Drug Landscape verified database"}